Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial-Reference-Cited by-同舟云学术

Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

Published:2008-04-14 Issue:1 Volume:1 Page:32-38
ISSN:1940-6207
Container-title:Cancer Prevention Research
language:en
Short-container-title:Cancer Prev Res

Author:

Meyskens Frank L.,McLaren Christine E.,Pelot Daniel,Fujikawa-Brooks Sharon,Carpenter Philip M.,Hawk Ernest,Kelloff Gary,Lawson Michael J.,Kidao Jayashri,McCracken John,Albers C. Gregory,Ahnen Dennis J.,Turgeon D. Kim,Goldschmid Steven,Lance Peter,Hagedorn Curt H.,Gillen Daniel L.,Gerner Eugene W.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 445 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P53-dependent hypusination of eIF5A affects mitochondrial translation and senescence immune surveillance;Nature Communications;2024-08-28

2. Endoscopic scoring indices for assessing disease severity in familial adenomatous polyposis: Systematic review;Endoscopy International Open;2024-06

3. A Contemporary Review on the Critical Role of Nonsteroidal Anti-inflammatory Agents in Colorectal Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2024-05

4. Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora;Orphanet Journal of Rare Diseases;2024-02-25

5. Macrophage Inflammatory Proteins (MIPs) Contribute to Malignant Potential of Colorectal Polyps and Modulate Likelihood of Cancerization Associated with Standard Risk Factors;International Journal of Molecular Sciences;2024-01-23